Activation of the Akt/mTOR pathway has been demonstrated as a major pathway involved in oral cancer, its lymph node metastasis, progression to advanced stages, chemoresistance, radioresistance, and poor survival outcomes [9,37,38,43,44,45,46]. This evidence concerns the gene AKT1 and lip and oral cavity carcinoma.